Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.


Updates from The Motley Fool

Latest updates on Navidea Biopharmaceuticals from Fool.com.


Stock Performance

NAVB vs. S&P 500 | 2 Year Performance
View Interactive NAVB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Navidea Biopharmaceuticals.
Current Price: $0.91
Prev Close: $0.89
Open: $0.94
Bid: $0.90
Ask: $0.94
Day's Range: $0.85 - $0.97
52wk Range: $0.26 - $2.40
Volume: 1,130,502
Avg Vol 4,078,251
Market Cap: $141.33M
P/E (ttm): -4.46
EPS (ttm): -$0.20
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Navidea Biopharmaceuticals.
CAPS Rating 1 out of 5
 
84 Outperform
30 Underperform
CAPS All Stars
 
8 Outperform
17 Underperform

How do you think Navidea Biopharmaceuticals will perform against the market?



You pick for Navidea Biopharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark J. Pykett, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Navidea Biopharmaceuticals.

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Healthcare IT